新的纳米注射系统提升了 doxorbicin 的癌症杀菌能力, A new nanoinjection system boosts doxorubicin’s cancer-killing power 23-fold and spares healthy tissue in lab tests.

来自IIT Madras、Monash和Deakin大学的团队开发了纳米注射系统,利用热稳定的纳米造影体和硅纳米管,直接向乳腺癌细胞中提供多氧菌素,在实验室测试中显示的药效比免费药物高23倍。 A team from IIT Madras, Monash, and Deakin Universities has developed a nanoinjection system that delivers doxorubicin directly into breast cancer cells using thermally stable nanoarchaeosomes and silicon nanotubes, showing 23 times greater potency than free drug in lab tests. 该平台减少了肿瘤血管的形成,杀死了癌症细胞,并避免了健康组织,有可能降低副作用和治疗成本。 The platform reduced tumor blood vessel formation, killed cancer cells, and spared healthy tissue, with potential to lower side effects and treatment costs. 目前正在准备进行活体测试和监管审查,可能用于其他癌症,并在中低收入国家扩大治疗范围。 It is being prepared for in vivo testing and regulatory review, with possible use in other cancers and broader access in low- and middle-income countries.